SYMSFYRE
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97408277
- Registration number
- 7674661
- Mark type
- Stylized text
- Filed
- 12 May 2022
- Published for opposition
- 12 Dec 2023
- Registered
- 04 Feb 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 19 Dec 2024 — NOTICE OF ALLOWANCE CANCELLED
- 19 Dec 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 24 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jul 2024 — SOU EXTENSION 1 GRANTED
- 22 Jul 2024 — SOU EXTENSION 1 FILED
- 22 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Dec 2023 — PUBLISHED FOR OPPOSITION
- 22 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED